Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 20-F, Date: 2016-07-29, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: KANG/20160729/20-F/1/000.htm SEC Original: a16-11673_120f.htm
FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report. . . . . . . . . . . . . . . . . . . . For the transition period from to iKang Healthcare Group, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) B-6F, Shimao Tower 92A

---

---

Webplus: KANG/20160729/20-F/2_EX-4.36/000.htm SEC Original: a16-11673_1ex4d36.htm
New China Life Insurance Co., Ltd. (“NCI”), iKang Guobin Healthcare Group Co., Ltd. (“iKang”), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (“Top Spring Pu Chang”) and New China Life Insurance Health Investment Management Co., Ltd. (the “Target Company”) entered into the Capital Injection Agreement (the “Agreement”) on December 4, 2015, as supplemented by the Supplemental Agreement to the

---

---

Webplus: KANG/20160729/20-F/3_EX-4.37/000.htm SEC Original: a16-11673_1ex4d37.htm
iKang Healthcare Technology Group Co., Ltd. (the “Borrower”) and AVIC Trust Co., Ltd. (the “Lender”) entered into the Loan Agreement (the “Agreement”) on December 9, 2015. Article 1. The Loan Amount The amount of loan (“Loan”) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 2.2 Article 3. Term of the Loan. 3.1 3.2 1 3.3 3.4 3.5 3.6

---

---

Webplus: KANG/20160729/20-F/4_EX-4.38/000.htm SEC Original: a16-11673_1ex4d38.htm
Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) (i) 1

---

---

Webplus: KANG/20160729/20-F/5_EX-4.39/000.htm SEC Original: a16-11673_1ex4d39.htm
Zhongjin Zhide Equity Investment Management Co., Ltd. (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) 1 (i) (ii) (1) (2) (3) (4) 2 (5) Article 4. Event of Default (1) (2) (3) (4)

---

---

Webplus: KANG/20160729/20-F/6_EX-4.40/000.htm SEC Original: a16-11673_1ex4d40.htm
Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (“Party A”), iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (“Party C”) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of

---

---

Webplus: KANG/20160729/20-F/7_EX-8.1/000.htm SEC Original: a16-11673_1ex8d1.htm
List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong Medifast (Hong Kong) Ltd. (Causeway Bay Branch) Hong Kong Medifast (Hong Kong) Ltd. (Kowloon Branch)

---

---

Webplus: KANG/20160729/20-F/8_EX-12.1/000.htm SEC Original: a16-11673_1ex12d1.htm
I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: KANG/20160729/20-F/9_EX-12.2/000.htm SEC Original: a16-11673_1ex12d2.htm
Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: KANG/20160729/20-F/10_EX-13.1/000.htm SEC Original: a16-11673_1ex13d1.htm
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 2016 EX-13.1 10 a16-11673_1ex13d1.htm EX-13.1

---

---

Webplus: KANG/20160729/20-F/11_EX-13.2/000.htm SEC Original: a16-11673_1ex13d2.htm
Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 201 EX-13.2 11 a16-11673_1ex13d2.htm EX-13.2

---

---

Webplus: KANG/20160729/20-F/12_EX-15.1/000.htm SEC Original: a16-11673_1ex15d1.htm
15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 Anna.Chong@conyersdill.com Charissa.Ball@conyersdill.com The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) Form 20-F Yours faithfully, EX-15.1 12 a16-11673_1ex15d1.htm EX-15.1

---

---

Webplus: KANG/20160729/20-F/13_EX-15.2/000.htm SEC Original: a16-11673_1ex15d2.htm
July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure” in iKang Healthcare Group, Inc.’s annual report on Form 20-F for the year

---

---

Webplus: KANG/20160729/20-F/14_EX-15.3/000.htm SEC Original: a16-11673_1ex15d3.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and Beijing, the People’s Republic of China July 29, 2016 EX-15.3 14 a16-11673_1ex15d3.htm EX-15.3

---

Company Information:

Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 20-F, Date: 2016-07-29, XBRL Interactive FinancialsCIK: 0001524190, Location: F4, SIC: 8011, SIC Desc: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Business Phone & Address:
B-6F, SHIMAO TOWER, 92A JIANGUO ROAD, CHAOYANG DISTRICT
Beijing 100022